Active Pharmaceutical Ingredients (API) Market - Global Outlook & Forecast 2021-2026
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Active Pharmaceutical Ingredients Market Report
The active pharmaceutical ingredients market is expected to reach USD 266.80 billion by 2026, growing at a CAGR of 6.22%.
The following factors are likely to contribute to the growth of the active pharmaceutical ingredients market during the forecast period:
Digitalization, big data, and artificial intelligence are accelerating the transformation of the pharmaceutical industry. The growing trend toward new high-tech therapeutics, with the emergence of novel and innovative delivery systems, the evolution of personalized medicines, will emphasize the growing demand for advanced APIs further. Innovative and Biotech APIs are fueling the demand for APIs across the globe. The global active pharmaceutical ingredient (API) market is set to have significant growth in the forecasted period. The growth of the market can be amplified by the growing geriatric and aging population globally. Manufacturers are significantly investing in Research and development and must continue spending on research and development initiatives. As the industry is getting fragmented and profit margins are thin, there is a need for constant innovation.
SNIPPETS
This research report includes a detailed segmentation by
The North American region is highly fragmented, and many global and regional players are present in the active pharmaceutical ingredient industry. Pharmaceutical manufacturers have increased the investments in R&D for the development of better-quality APIs since it has a direct effect on the safety and efficacy of the drug. The North American API industry is anticipated to show increasing growth in the forecasted period.
Market Segmentation by Geography
The global API market is highly concentrated and competitive. Pfizer, Cipla, Novartis AG, Mylan NV, and Sun Pharmaceuticals are prominent vendors in the industry. Over the past decade, several companies have engaged in mergers and acquisitions to establish their presence in the industry. Mergers and acquisitions offer several benefits, such as better access to procuring raw materials, distribution, and R&D, and are largely driven by consolidation. Manufacturers must always keep pace with the latest industry regulations for manufacturing APIs to avoid penalties and criminal sanctions. The demand for APIs is expected to accelerate due to the increase in the geriatric population and the increase in awareness for better healthcare.
Key Vendors
1. How big is the active pharmaceutical ingredient market?
2. What are the different applications in the global active pharmaceutical ingredient market?
3. Who are the key players in the active pharmaceutical ingredient (API) market?
4. What are the latest trends in the active pharmaceutical ingredient market?
5. What are the key driving factors in the global API market?
The active pharmaceutical ingredients market is expected to reach USD 266.80 billion by 2026, growing at a CAGR of 6.22%.
The following factors are likely to contribute to the growth of the active pharmaceutical ingredients market during the forecast period:
- The invention of new generation API
- Increase in Demand for Generic Drugs
- High Adoption of Mergers and Acquisitions
- Impact of API Outsourcing
Digitalization, big data, and artificial intelligence are accelerating the transformation of the pharmaceutical industry. The growing trend toward new high-tech therapeutics, with the emergence of novel and innovative delivery systems, the evolution of personalized medicines, will emphasize the growing demand for advanced APIs further. Innovative and Biotech APIs are fueling the demand for APIs across the globe. The global active pharmaceutical ingredient (API) market is set to have significant growth in the forecasted period. The growth of the market can be amplified by the growing geriatric and aging population globally. Manufacturers are significantly investing in Research and development and must continue spending on research and development initiatives. As the industry is getting fragmented and profit margins are thin, there is a need for constant innovation.
SNIPPETS
- Based on Molecule type, the small molecule is the largest segment with a 5.82% growth rate in 2021 and is projected to show a 6.95% growth rate in 2026.
- Current trends like an increase in demand for biopharmaceuticals and naturally derived APIs will increase the demand and growth in the market.
This research report includes a detailed segmentation by
- Application
- Molecule Type
- Type of manufacturers
- Type of drugs
- Synthesis Type
- The increasing awareness of various APIs' improved efficacy on targeted cancerous cells is also propelling their demand for oncology drugs. Oncology API will register a growth rate of 7.33% in 2021, and it will increase up to 8.18% in 2026.
- The rise in internet penetration enables various online platforms to collaborate with pharmaceutical companies to deliver drugs such as analgesics at the doorstep of consumers. The global active pharmaceutical ingredients industry by pain management API will grow at a CAGR of 5.76% during the forecast period.
- Oncology
- Cardiovascular Disease
- Anti-infectives
- Central Nervous System
- Respiratory diseases
- Diabetes
- Pain management
- Others
- Small
- Large
- Captive
- Merchant
- Prescription
- Over the counter
- Synthetic
- Biotech
The North American region is highly fragmented, and many global and regional players are present in the active pharmaceutical ingredient industry. Pharmaceutical manufacturers have increased the investments in R&D for the development of better-quality APIs since it has a direct effect on the safety and efficacy of the drug. The North American API industry is anticipated to show increasing growth in the forecasted period.
Market Segmentation by Geography
- North America
- US
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Russia
- APAC
- China
- India
- Indonesia
- Japan
- Singapore
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
The global API market is highly concentrated and competitive. Pfizer, Cipla, Novartis AG, Mylan NV, and Sun Pharmaceuticals are prominent vendors in the industry. Over the past decade, several companies have engaged in mergers and acquisitions to establish their presence in the industry. Mergers and acquisitions offer several benefits, such as better access to procuring raw materials, distribution, and R&D, and are largely driven by consolidation. Manufacturers must always keep pace with the latest industry regulations for manufacturing APIs to avoid penalties and criminal sanctions. The demand for APIs is expected to accelerate due to the increase in the geriatric population and the increase in awareness for better healthcare.
Key Vendors
- Pfizer Inc.
- Cipla Inc.
- Novartis AG
- Mylan N.V.
- Sun Pharmaceuticals Industries Ltd.
- Albemarle Corporation
- AbbVie Inc.
- Reddy’s Laboratories Ltd.
- Eli Lilly and Company
- Teva Pharmaceuticals Industries Ltd.
- Bristol-Myers Squibb
- Aurobindo Pharma limited
- Sanofi
- Boehringer Ingelheim International GmbH
- BASF SE
- Lupin
- Shenzhen Hepalink Pharmaceutical Group Ltd.
- Abbott
- Biocon
- Amgen Inc.
- GlaxoSmithKline Plc
- Hoffmann-La Roche Ltd.
- Merck KGaA
- Viatris Inc.,
- Glenmark Pharmaceuticals
1. How big is the active pharmaceutical ingredient market?
2. What are the different applications in the global active pharmaceutical ingredient market?
3. Who are the key players in the active pharmaceutical ingredient (API) market?
4. What are the latest trends in the active pharmaceutical ingredient market?
5. What are the key driving factors in the global API market?
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 Market Definition
4.01.01 Inclusions
4.01.02 Exclusions
4.01.03 Market Estimation Caveats
4.2 Base Year
4.3 Scope Of The Study
4.03.01 Market Segmentation By Geography
5 REPORT ASSUMPTIONS & CAVEATS
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 Overview
7.2 Impact Of Covid-19
8 GROWTH OPPORTUNITY BY SEGMENT
8.1 By Application
8.2 By Molecule
8.3 By Manufacturers
8.4 By Synthesis
8.5 By Drug Type
8.6 By Geography
9 MARKET OPPORTUNITIES &TRENDS
9.1 Growing Demand For Generic Drugs
9.2 Increasing Digitalization In Healthcare
9.3 Mergers & Acquisitions In Pharmaceutical Industry
10 MARKET GROWTH ENABLERS
10.1 Invention Of New Generation APIs
10.2 Growth In API Outsourcing Operations
11 MARKET GROWTH RESTRAINTS
11.1 Stringent Government Regulations
11.2 Analytical Challenges In Testing Processes
12 MARKET LANDSCAPE
12.1 Market Overview
12.2 Market Size & Forecast
12.3 Five Forces Analysis
12.03.01 Threat Of New Entrants
12.03.02 Bargaining Power Of Suppliers
12.03.03 Bargaining Power Of Buyers
12.03.04 Threat Of Substitutes
12.03.05 Competitive Rivalry
13 APPLICATION
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Oncology
13.03.01 Market Overview
13.03.02 Market Size & Forecast
13.03.03 Market By Geography
13.4 Diabetes
13.04.01 Market Overview
13.04.02 Market Size & Forecast
13.04.03 Market By Geography
13.5 Cardiovascular
13.05.01 Market Overview
13.05.02 Market Size & Forecast
13.05.03 Market By Geography
13.6 Respiratory Diseases
13.06.01 Market Overview
13.06.02 Market Size & Forecast
13.06.03 Market By Geography
13.7 Pain Management
13.07.01 Market Overview
13.07.02 Market Size & Forecast
13.07.03 Market By Geography
13.8 Anti-Infectives
13.08.01 Market Overview
13.08.02 Market Size & Forecast
13.08.03 Market By Geography
13.9 Central Nervous System
13.09.01 Market Overview
13.09.02 Market Size & Forecast
13.09.03 Market By Geography
14 MOLECULE SIZE
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Small Molecule
14.03.01 Market Overview
14.03.02 Market Size & Forecast
14.03.03 Market By Geography
14.4 Large Molecule
14.04.01 Market Overview
14.04.02 Market Size & Forecast
14.04.03 Market By Geography
15 TYPE OF MANUFACTURERS
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Captive Manufacturing
15.03.01 Market Overview
15.03.02 Market Size & Forecast
15.03.03 Market By Geography
15.4 Merchant Manufacturing
15.04.01 Market Overview
15.04.02 Market Size & Forecast
15.04.03 Market By Geography
16 TYPES OF DRUGS
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Over-The-Counter Drugs
16.03.01 Market Overview
16.03.02 Market Size & Forecast
16.03.03 Market By Geography
16.4 Prescription Drugs
16.04.01 Market Overview
16.04.02 Market Size & Forecast
16.04.03 Market By Geography
17 SYNTHESIS TYPE
17.1 Market Snapshot & Growth Engine
17.2 Market Overview
17.3 Synthetic API
17.03.01 Market Overview
17.03.02 Market Size & Forecast
17.03.03 Market By Geography
17.4 Biotech API
17.04.01 Market Overview
17.04.02 Market Size & Forecast
17.04.03 Market By Geography
18 GEOGRAPHY
18.1 Market Snapshot & Growth Engine
18.2 Geographic Overview
19 NORTH AMERICA
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Application
19.03.01 Market Size & Forecast
19.4 Molecule
19.04.01 Market Size & Forecast
19.5 Manufacturers
19.05.01 Market Size & Forecast
19.6 Synthesis Type
19.06.01 Market Size & Forecast
19.7 Type Of Drugs
19.07.01 Market Size & Forecast
19.8 Key Countries
19.08.01 Us: Market Size & Forecast
19.08.02 Canada: Market Size & Forecast
20 EUROPE
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Application
20.03.01 Market Size & Forecast
20.4 Molecule
20.04.01 Market Size & Forecast
20.5 Manufacturers
20.05.01 Market Size & Forecast
20.6 Synthesis Type
20.06.01 Market Size & Forecast
20.7 Type Of Drugs
20.07.01 Market Size & Forecast
20.8 Key Countries
20.08.01 UK: Market Size & Forecast
20.08.02 Germany: Market Size & Forecast
20.08.03 France: Market Size & Forecast
20.08.04 Italy: Market Size & Forecast
20.08.05 Spain: Market Size & Forecast
20.08.06 Russia: Market Size & Forecast
21 APAC
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Application
21.03.01 Market Size & Forecast
21.4 Molecule
21.04.01 Market Size & Forecast
21.5 Manufacturers
21.05.01 Market Size & Forecast
21.6 Synthesis Type
21.06.01 Market Size & Forecast
21.7 Type Of Drugs
21.07.01 Market Size & Forecast
21.8 Key Countries
21.08.01 China: Market Size & Forecast
21.08.02 India: Market Size & Forecast
21.08.03 Indonesia: Market Size & Forecast
21.08.04 Japan: Market Size & Forecast
21.08.05 Singapore: Market Size & Forecast
22 LATIN AMERICA
22.1 Market Overview
22.2 Market Size & Forecast
22.3 Application
22.03.01 Market Size & Forecast
22.4 Molecule
22.04.01 Market Size & Forecast
22.5 Manufacturers
22.05.01 Market Size & Forecast
22.6 Synthesis Type
22.06.01 Market Size & Forecast
22.7 Type Of Drugs
22.07.01 Market Size & Forecast
22.8 Key Countries
22.08.01 Brazil: Market Size & Forecast
22.08.02 Mexico: Market Size & Forecast
23 MIDDLE EAST & AFRICA
23.1 Market Overview
23.2 Market Size & Forecast
23.3 Application
23.03.01 Market Size & Forecast
23.4 Molecule
23.04.01 Market Size & Forecast
23.5 Manufacturers
23.05.01 Market Size & Forecast
23.6 Synthesis Type
23.06.01 Market Size & Forecast
23.7 Type Of Drugs
23.07.01 Market Size & Forecast
23.8 Key Countries
23.08.01 Saudi Arabia: Market Size & Forecast
23.08.02 South Africa: Market Size & Forecast
23.08.03 UAE: Market Size & Forecast
24 COMPETITIVE LANDSCAPE
24.1 Competition Overview
25 KEY COMPANY PROFILES
25.1 PFIZER INC.
25.01.01 Business Overview
25.01.02 Pfizer Inc. in Global Active Pharmaceutical Ingredients Market
25.01.03 Product Offerings
25.01.04 Key Strategies
25.01.05 Key Strengths
25.01.06 Key Opportunities
25.2 CIPLA INC.
25.02.01 Business Overview
25.02.02 Cipla Inc. in Global Active Pharmaceutical Ingredients Market
25.02.03 Product Offerings
25.02.04 Key Strategies
25.02.05 Key Strengths
25.02.06 Key Opportunities
25.3 NOVARTIS AG
25.03.01 Business Overview
26 OTHER PROMINENT VENDORS
26.1 ALBEMARLE CORPORATION
26.01.01 Business Overview
26.01.02 Key Highlights
26.2 ABBVIE INC.
26.02.01 Business Overview
26.02.02 Key Highlights
26.3 DR. REDDY’S LABORATORIES LTD.
26.03.01 Business Overview
26.03.02 Key Highlights
26.4 ELI LILLY AND COMPANY
26.04.01 Business Overview
26.04.02 Key Highlights
26.5 TEVA PHARMACEUTICAL INDUSTRIES LTD.
26.05.01 Business Overview
26.05.02 Key Highlights
26.6 BRISTOL-MYERS SQUIBB
26.06.01 Business Overview
26.06.02 Key Highlights
26.7 AUROBINDO PHARMA
26.07.01 Business Overview
26.07.02 Key Highlights
26.8 SANOFI
26.08.01 Business Overview
26.08.02 Key Highlights
26.9 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
26.09.01 Business Overview
26.09.02 Key Highlights
26.10 BASF SE
26.10.01 Business Overview
26.10.02 Key Highlights
26.11 LUPIN
26.11.01 Business Overview
26.11.02 Key Highlights
26.12 SHENZHEN HEPALINK PHARMACEUTICAL GROUP
26.12.01 Business Overview
26.12.02 Key Highlights
26.13 ABBOTT
26.13.01 Business Overview
26.13.02 Key Highlights
26.14 BIOCON
26.14.01 Business Overview
26.14.02 Key Highlights
26.15 AMGEN INC.
26.15.01 Business Overview
26.15.02 Key Highlights
26.16 GLAXOSMITHKLINE PLC.
26.16.01 Business Overview
26.16.02 Key Highlights
26.17 F. HOFFMANN-LA ROCHE LTD.
26.17.01 Business Overview
26.17.02 Key Highlights
26.18 MERCK KGAA
26.18.01 Business Overview
26.18.02 Key Highlights
26.19 VIATRIS INC.
26.19.01 Business Overview
26.19.02 Key Highlights
26.20 GLENMARK PHARMACEUTICALS
26.20.01 Business Overview
26.20.02 Key Highlights
27 REPORT SUMMARY
27.1 Key Takeaways
27.2 Strategic Recommendations
28 QUANTITATIVE SUMMARY
28.1 Application
28.01.01 Oncology
28.01.02 Cardiovascular Disease
28.01.03 Anti-infectives
28.01.04 CNS
28.01.05 Pain Management
28.01.06 Diabetes
28.01.07 Respiratory Disease
28.2 MOLECULE TYPE
28.02.01 Small Molecule
28.02.02 Large Molecule API
28.3 SYNTHESIS TYPE
28.03.01 Synthetic API
28.03.02 Biotech API
28.4 MANUFACTURERS
28.04.01 Captive Manufacturing
28.04.02 Merchant Manufacturing
28.5 DRUG TYPE
28.05.01 Over-the-counter drugs
28.05.02 Prescription Drugs API
28.6 GEOGRAPHY
28.06.01 North America
28.06.02 Europe
28.06.03 APAC
28.06.04 Latin America
28.06.05 Middle East and Africa
29 APPENDIX
29.1 Abbreviations
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 Market Definition
4.01.01 Inclusions
4.01.02 Exclusions
4.01.03 Market Estimation Caveats
4.2 Base Year
4.3 Scope Of The Study
4.03.01 Market Segmentation By Geography
5 REPORT ASSUMPTIONS & CAVEATS
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 Overview
7.2 Impact Of Covid-19
8 GROWTH OPPORTUNITY BY SEGMENT
8.1 By Application
8.2 By Molecule
8.3 By Manufacturers
8.4 By Synthesis
8.5 By Drug Type
8.6 By Geography
9 MARKET OPPORTUNITIES &TRENDS
9.1 Growing Demand For Generic Drugs
9.2 Increasing Digitalization In Healthcare
9.3 Mergers & Acquisitions In Pharmaceutical Industry
10 MARKET GROWTH ENABLERS
10.1 Invention Of New Generation APIs
10.2 Growth In API Outsourcing Operations
11 MARKET GROWTH RESTRAINTS
11.1 Stringent Government Regulations
11.2 Analytical Challenges In Testing Processes
12 MARKET LANDSCAPE
12.1 Market Overview
12.2 Market Size & Forecast
12.3 Five Forces Analysis
12.03.01 Threat Of New Entrants
12.03.02 Bargaining Power Of Suppliers
12.03.03 Bargaining Power Of Buyers
12.03.04 Threat Of Substitutes
12.03.05 Competitive Rivalry
13 APPLICATION
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Oncology
13.03.01 Market Overview
13.03.02 Market Size & Forecast
13.03.03 Market By Geography
13.4 Diabetes
13.04.01 Market Overview
13.04.02 Market Size & Forecast
13.04.03 Market By Geography
13.5 Cardiovascular
13.05.01 Market Overview
13.05.02 Market Size & Forecast
13.05.03 Market By Geography
13.6 Respiratory Diseases
13.06.01 Market Overview
13.06.02 Market Size & Forecast
13.06.03 Market By Geography
13.7 Pain Management
13.07.01 Market Overview
13.07.02 Market Size & Forecast
13.07.03 Market By Geography
13.8 Anti-Infectives
13.08.01 Market Overview
13.08.02 Market Size & Forecast
13.08.03 Market By Geography
13.9 Central Nervous System
13.09.01 Market Overview
13.09.02 Market Size & Forecast
13.09.03 Market By Geography
14 MOLECULE SIZE
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Small Molecule
14.03.01 Market Overview
14.03.02 Market Size & Forecast
14.03.03 Market By Geography
14.4 Large Molecule
14.04.01 Market Overview
14.04.02 Market Size & Forecast
14.04.03 Market By Geography
15 TYPE OF MANUFACTURERS
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Captive Manufacturing
15.03.01 Market Overview
15.03.02 Market Size & Forecast
15.03.03 Market By Geography
15.4 Merchant Manufacturing
15.04.01 Market Overview
15.04.02 Market Size & Forecast
15.04.03 Market By Geography
16 TYPES OF DRUGS
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Over-The-Counter Drugs
16.03.01 Market Overview
16.03.02 Market Size & Forecast
16.03.03 Market By Geography
16.4 Prescription Drugs
16.04.01 Market Overview
16.04.02 Market Size & Forecast
16.04.03 Market By Geography
17 SYNTHESIS TYPE
17.1 Market Snapshot & Growth Engine
17.2 Market Overview
17.3 Synthetic API
17.03.01 Market Overview
17.03.02 Market Size & Forecast
17.03.03 Market By Geography
17.4 Biotech API
17.04.01 Market Overview
17.04.02 Market Size & Forecast
17.04.03 Market By Geography
18 GEOGRAPHY
18.1 Market Snapshot & Growth Engine
18.2 Geographic Overview
19 NORTH AMERICA
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Application
19.03.01 Market Size & Forecast
19.4 Molecule
19.04.01 Market Size & Forecast
19.5 Manufacturers
19.05.01 Market Size & Forecast
19.6 Synthesis Type
19.06.01 Market Size & Forecast
19.7 Type Of Drugs
19.07.01 Market Size & Forecast
19.8 Key Countries
19.08.01 Us: Market Size & Forecast
19.08.02 Canada: Market Size & Forecast
20 EUROPE
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Application
20.03.01 Market Size & Forecast
20.4 Molecule
20.04.01 Market Size & Forecast
20.5 Manufacturers
20.05.01 Market Size & Forecast
20.6 Synthesis Type
20.06.01 Market Size & Forecast
20.7 Type Of Drugs
20.07.01 Market Size & Forecast
20.8 Key Countries
20.08.01 UK: Market Size & Forecast
20.08.02 Germany: Market Size & Forecast
20.08.03 France: Market Size & Forecast
20.08.04 Italy: Market Size & Forecast
20.08.05 Spain: Market Size & Forecast
20.08.06 Russia: Market Size & Forecast
21 APAC
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Application
21.03.01 Market Size & Forecast
21.4 Molecule
21.04.01 Market Size & Forecast
21.5 Manufacturers
21.05.01 Market Size & Forecast
21.6 Synthesis Type
21.06.01 Market Size & Forecast
21.7 Type Of Drugs
21.07.01 Market Size & Forecast
21.8 Key Countries
21.08.01 China: Market Size & Forecast
21.08.02 India: Market Size & Forecast
21.08.03 Indonesia: Market Size & Forecast
21.08.04 Japan: Market Size & Forecast
21.08.05 Singapore: Market Size & Forecast
22 LATIN AMERICA
22.1 Market Overview
22.2 Market Size & Forecast
22.3 Application
22.03.01 Market Size & Forecast
22.4 Molecule
22.04.01 Market Size & Forecast
22.5 Manufacturers
22.05.01 Market Size & Forecast
22.6 Synthesis Type
22.06.01 Market Size & Forecast
22.7 Type Of Drugs
22.07.01 Market Size & Forecast
22.8 Key Countries
22.08.01 Brazil: Market Size & Forecast
22.08.02 Mexico: Market Size & Forecast
23 MIDDLE EAST & AFRICA
23.1 Market Overview
23.2 Market Size & Forecast
23.3 Application
23.03.01 Market Size & Forecast
23.4 Molecule
23.04.01 Market Size & Forecast
23.5 Manufacturers
23.05.01 Market Size & Forecast
23.6 Synthesis Type
23.06.01 Market Size & Forecast
23.7 Type Of Drugs
23.07.01 Market Size & Forecast
23.8 Key Countries
23.08.01 Saudi Arabia: Market Size & Forecast
23.08.02 South Africa: Market Size & Forecast
23.08.03 UAE: Market Size & Forecast
24 COMPETITIVE LANDSCAPE
24.1 Competition Overview
25 KEY COMPANY PROFILES
25.1 PFIZER INC.
25.01.01 Business Overview
25.01.02 Pfizer Inc. in Global Active Pharmaceutical Ingredients Market
25.01.03 Product Offerings
25.01.04 Key Strategies
25.01.05 Key Strengths
25.01.06 Key Opportunities
25.2 CIPLA INC.
25.02.01 Business Overview
25.02.02 Cipla Inc. in Global Active Pharmaceutical Ingredients Market
25.02.03 Product Offerings
25.02.04 Key Strategies
25.02.05 Key Strengths
25.02.06 Key Opportunities
25.3 NOVARTIS AG
25.03.01 Business Overview
26 OTHER PROMINENT VENDORS
26.1 ALBEMARLE CORPORATION
26.01.01 Business Overview
26.01.02 Key Highlights
26.2 ABBVIE INC.
26.02.01 Business Overview
26.02.02 Key Highlights
26.3 DR. REDDY’S LABORATORIES LTD.
26.03.01 Business Overview
26.03.02 Key Highlights
26.4 ELI LILLY AND COMPANY
26.04.01 Business Overview
26.04.02 Key Highlights
26.5 TEVA PHARMACEUTICAL INDUSTRIES LTD.
26.05.01 Business Overview
26.05.02 Key Highlights
26.6 BRISTOL-MYERS SQUIBB
26.06.01 Business Overview
26.06.02 Key Highlights
26.7 AUROBINDO PHARMA
26.07.01 Business Overview
26.07.02 Key Highlights
26.8 SANOFI
26.08.01 Business Overview
26.08.02 Key Highlights
26.9 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
26.09.01 Business Overview
26.09.02 Key Highlights
26.10 BASF SE
26.10.01 Business Overview
26.10.02 Key Highlights
26.11 LUPIN
26.11.01 Business Overview
26.11.02 Key Highlights
26.12 SHENZHEN HEPALINK PHARMACEUTICAL GROUP
26.12.01 Business Overview
26.12.02 Key Highlights
26.13 ABBOTT
26.13.01 Business Overview
26.13.02 Key Highlights
26.14 BIOCON
26.14.01 Business Overview
26.14.02 Key Highlights
26.15 AMGEN INC.
26.15.01 Business Overview
26.15.02 Key Highlights
26.16 GLAXOSMITHKLINE PLC.
26.16.01 Business Overview
26.16.02 Key Highlights
26.17 F. HOFFMANN-LA ROCHE LTD.
26.17.01 Business Overview
26.17.02 Key Highlights
26.18 MERCK KGAA
26.18.01 Business Overview
26.18.02 Key Highlights
26.19 VIATRIS INC.
26.19.01 Business Overview
26.19.02 Key Highlights
26.20 GLENMARK PHARMACEUTICALS
26.20.01 Business Overview
26.20.02 Key Highlights
27 REPORT SUMMARY
27.1 Key Takeaways
27.2 Strategic Recommendations
28 QUANTITATIVE SUMMARY
28.1 Application
28.01.01 Oncology
28.01.02 Cardiovascular Disease
28.01.03 Anti-infectives
28.01.04 CNS
28.01.05 Pain Management
28.01.06 Diabetes
28.01.07 Respiratory Disease
28.2 MOLECULE TYPE
28.02.01 Small Molecule
28.02.02 Large Molecule API
28.3 SYNTHESIS TYPE
28.03.01 Synthetic API
28.03.02 Biotech API
28.4 MANUFACTURERS
28.04.01 Captive Manufacturing
28.04.02 Merchant Manufacturing
28.5 DRUG TYPE
28.05.01 Over-the-counter drugs
28.05.02 Prescription Drugs API
28.6 GEOGRAPHY
28.06.01 North America
28.06.02 Europe
28.06.03 APAC
28.06.04 Latin America
28.06.05 Middle East and Africa
29 APPENDIX
29.1 Abbreviations
LIST OF EXHIBITS
Exhibit 1 Segmentation of Global Active Pharmaceutical Ingredients Market
Exhibit 2 Market Size Calculation Approach 2020
Exhibit 3 Market Size of Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 4 Biotech API Manufacturing Process
Exhibit 5 Synthetic API Manufacturing Process
Exhibit 6 Growth Drivers in Global Active Pharmaceutical Ingredients Market
Exhibit 7 Global Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Exhibit 8 Global Active Pharmaceutical Ingredients Market by Molecule ($ billion)
Exhibit 9 Global Active Pharmaceutical Ingredients Market by Manufacturing ($ billion)
Exhibit 10 Global Active Pharmaceutical Ingredients Market by Synthesis ($ billion)
Exhibit 11 Global Active Pharmaceutical Ingredients Market by Drug Type ($ billion)
Exhibit 12 Global Active Pharmaceutical Ingredients Market by Geography ($ billion)
Exhibit 13 Impact of Growing Demand for Generic Drugs
Exhibit 14 Definition of Generic Medicine
Exhibit 15 Types of Generics
Exhibit 16 Impact of Increasing Digitalization in Healthcare
Exhibit 17 Impact of Mergers and Acquisitions in Pharmaceutical Industry
Exhibit 18 Strategies for Mergers & Acquisitions
Exhibit 19 Impact of Invention of New Generation APIs
Exhibit 20 Challenges with Peptide APIs
Exhibit 21 Impact of Growth in API Outsourcing Operations
Exhibit 22 Advantages of Outsourcing
Exhibit 23 Impact of Stringent Government Regulations
Exhibit 24 Impact of Analytical Challenges in Testing Processes
Exhibit 25 Current Trends in Global APIs Market
Exhibit 26 Global Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 27 Five Forces Analysis 2020
Exhibit 28 Incremental Growth by Application 2020 & 2026
Exhibit 29 Global Oncology Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 30 Global Diabetes Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 31 Global Cardiovascular Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 32 Global Respiratory Diseases Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 33 Global Pain Management Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 34 Global Anti-infective Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 35 Global CNS Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 36 Incremental Growth by Molecule 2020 & 2026
Exhibit 37 Global Active Pharmaceutical Ingredients Market by Molecule Size (% share)
Exhibit 38 Global Small Molecule Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 39 Global Large Molecule Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 40 Incremental Growth by Manufacturing 2020 & 2026
Exhibit 41 Advantages of Merchant Manufacturing
Exhibit 42 Advantages of Captive Manufacturing
Exhibit 43 Global Captive Manufacturing Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 44 Challenges in Outsourcing
Exhibit 45 Advantages of Contract Manufacturing
Exhibit 46 Global Merchant Manufacturing APIs Market 2020–2026 ($ billion)
Exhibit 47 Incremental Growth by Drugs 2020 & 2026
Exhibit 48 Key Differences
Exhibit 49 Global OTC Drugs Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 50 Global Prescription Drugs Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 51 Incremental Growth by Synthesis 2020 & 2026
Exhibit 52 Global Synthetic Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 53 Global Biotech Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 54 Incremental Growth by Geography 2020 & 2026
Exhibit 55 Global Active Pharmaceutical Ingredients Market by Region (CAGR %)
Exhibit 56 North America Active Pharmaceutical Ingredients Market 2020–2026
Exhibit 57 North America Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 58 Incremental Growth in North America 2020 & 2026
Exhibit 59 Active Pharmaceutical Ingredients Market in US 2020–2026 ($ billion)
Exhibit 60 Active Pharmaceutical Ingredients Market in Canada 2020–2026 ($ billion)
Exhibit 61 Factors Fueling Success of CMOs in Europe
Exhibit 62 Europe Global Active Pharmaceutical Ingredients Market
Exhibit 63 Europe Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 64 Incremental Growth in Europe 2020 & 2026
Exhibit 65 Active Pharmaceutical Ingredients Market in UK 2020–2026 ($ billion)
Exhibit 66 Active Pharmaceutical Ingredients Market in Germany 2020–2026 ($ billion)
Exhibit 67 Active Pharmaceutical Ingredients Market in France 2020–2026 ($ billion)
Exhibit 68 Active Pharmaceutical Ingredients Market in Italy 2020–2026 ($ billion)
Exhibit 69 Active Pharmaceutical Ingredients Market in Spain 2020–2026 ($ billion)
Exhibit 70 Active Pharmaceutical Ingredients Market in Russia 2020–2026 ($ billion)
Exhibit 71 APAC Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 72 Incremental Growth in APAC 2020 & 2026
Exhibit 73 Active Pharmaceutical Ingredients Market in China 2020–2026 ($ billion)
Exhibit 74 Active Pharmaceutical Ingredients Market in India 2020–2026 ($ billion)
Exhibit 75 Challenges Faced by Indian API Industry
Exhibit 76 Active Pharmaceutical Ingredients Market in Indonesia 2020–2026 ($ billion)
Exhibit 77 Active Pharmaceutical Ingredients Market in Japan 2020–2026 ($ billion)
Exhibit 78 Active Pharmaceutical Ingredients Market in Singapore 2020–2026 ($ billion)
Exhibit 79 Latin America Global Active Pharmaceutical Ingredients Market
Exhibit 80 Latin America Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 81 Incremental Growth in Latin America 2020 & 2026
Exhibit 82 Active Pharmaceutical Ingredients Market in Brazil 2020–2026 ($ billion)
Exhibit 83 Active Pharmaceutical Ingredients Market in Mexico 2020–2026 ($ billion)
Exhibit 84 Middle East & Africa Active Pharmaceutical Ingredients Market
Exhibit 85 Middle East & Africa Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 86 Incremental Growth in Middle East & Africa 2020 & 2026
Exhibit 87 Active Pharmaceutical Ingredients Market in Saudi Arabia 2020–2026 ($ billion)
Exhibit 88 Active Pharmaceutical Ingredients Market in South Africa 2020–2026 ($ billion)
Exhibit 89 Active Pharmaceutical Ingredients Market in UAE 2020–2026 ($ billion)
Exhibit 1 Segmentation of Global Active Pharmaceutical Ingredients Market
Exhibit 2 Market Size Calculation Approach 2020
Exhibit 3 Market Size of Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 4 Biotech API Manufacturing Process
Exhibit 5 Synthetic API Manufacturing Process
Exhibit 6 Growth Drivers in Global Active Pharmaceutical Ingredients Market
Exhibit 7 Global Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Exhibit 8 Global Active Pharmaceutical Ingredients Market by Molecule ($ billion)
Exhibit 9 Global Active Pharmaceutical Ingredients Market by Manufacturing ($ billion)
Exhibit 10 Global Active Pharmaceutical Ingredients Market by Synthesis ($ billion)
Exhibit 11 Global Active Pharmaceutical Ingredients Market by Drug Type ($ billion)
Exhibit 12 Global Active Pharmaceutical Ingredients Market by Geography ($ billion)
Exhibit 13 Impact of Growing Demand for Generic Drugs
Exhibit 14 Definition of Generic Medicine
Exhibit 15 Types of Generics
Exhibit 16 Impact of Increasing Digitalization in Healthcare
Exhibit 17 Impact of Mergers and Acquisitions in Pharmaceutical Industry
Exhibit 18 Strategies for Mergers & Acquisitions
Exhibit 19 Impact of Invention of New Generation APIs
Exhibit 20 Challenges with Peptide APIs
Exhibit 21 Impact of Growth in API Outsourcing Operations
Exhibit 22 Advantages of Outsourcing
Exhibit 23 Impact of Stringent Government Regulations
Exhibit 24 Impact of Analytical Challenges in Testing Processes
Exhibit 25 Current Trends in Global APIs Market
Exhibit 26 Global Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 27 Five Forces Analysis 2020
Exhibit 28 Incremental Growth by Application 2020 & 2026
Exhibit 29 Global Oncology Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 30 Global Diabetes Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 31 Global Cardiovascular Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 32 Global Respiratory Diseases Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 33 Global Pain Management Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 34 Global Anti-infective Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 35 Global CNS Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 36 Incremental Growth by Molecule 2020 & 2026
Exhibit 37 Global Active Pharmaceutical Ingredients Market by Molecule Size (% share)
Exhibit 38 Global Small Molecule Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 39 Global Large Molecule Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 40 Incremental Growth by Manufacturing 2020 & 2026
Exhibit 41 Advantages of Merchant Manufacturing
Exhibit 42 Advantages of Captive Manufacturing
Exhibit 43 Global Captive Manufacturing Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 44 Challenges in Outsourcing
Exhibit 45 Advantages of Contract Manufacturing
Exhibit 46 Global Merchant Manufacturing APIs Market 2020–2026 ($ billion)
Exhibit 47 Incremental Growth by Drugs 2020 & 2026
Exhibit 48 Key Differences
Exhibit 49 Global OTC Drugs Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 50 Global Prescription Drugs Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 51 Incremental Growth by Synthesis 2020 & 2026
Exhibit 52 Global Synthetic Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 53 Global Biotech Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 54 Incremental Growth by Geography 2020 & 2026
Exhibit 55 Global Active Pharmaceutical Ingredients Market by Region (CAGR %)
Exhibit 56 North America Active Pharmaceutical Ingredients Market 2020–2026
Exhibit 57 North America Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 58 Incremental Growth in North America 2020 & 2026
Exhibit 59 Active Pharmaceutical Ingredients Market in US 2020–2026 ($ billion)
Exhibit 60 Active Pharmaceutical Ingredients Market in Canada 2020–2026 ($ billion)
Exhibit 61 Factors Fueling Success of CMOs in Europe
Exhibit 62 Europe Global Active Pharmaceutical Ingredients Market
Exhibit 63 Europe Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 64 Incremental Growth in Europe 2020 & 2026
Exhibit 65 Active Pharmaceutical Ingredients Market in UK 2020–2026 ($ billion)
Exhibit 66 Active Pharmaceutical Ingredients Market in Germany 2020–2026 ($ billion)
Exhibit 67 Active Pharmaceutical Ingredients Market in France 2020–2026 ($ billion)
Exhibit 68 Active Pharmaceutical Ingredients Market in Italy 2020–2026 ($ billion)
Exhibit 69 Active Pharmaceutical Ingredients Market in Spain 2020–2026 ($ billion)
Exhibit 70 Active Pharmaceutical Ingredients Market in Russia 2020–2026 ($ billion)
Exhibit 71 APAC Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 72 Incremental Growth in APAC 2020 & 2026
Exhibit 73 Active Pharmaceutical Ingredients Market in China 2020–2026 ($ billion)
Exhibit 74 Active Pharmaceutical Ingredients Market in India 2020–2026 ($ billion)
Exhibit 75 Challenges Faced by Indian API Industry
Exhibit 76 Active Pharmaceutical Ingredients Market in Indonesia 2020–2026 ($ billion)
Exhibit 77 Active Pharmaceutical Ingredients Market in Japan 2020–2026 ($ billion)
Exhibit 78 Active Pharmaceutical Ingredients Market in Singapore 2020–2026 ($ billion)
Exhibit 79 Latin America Global Active Pharmaceutical Ingredients Market
Exhibit 80 Latin America Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 81 Incremental Growth in Latin America 2020 & 2026
Exhibit 82 Active Pharmaceutical Ingredients Market in Brazil 2020–2026 ($ billion)
Exhibit 83 Active Pharmaceutical Ingredients Market in Mexico 2020–2026 ($ billion)
Exhibit 84 Middle East & Africa Active Pharmaceutical Ingredients Market
Exhibit 85 Middle East & Africa Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 86 Incremental Growth in Middle East & Africa 2020 & 2026
Exhibit 87 Active Pharmaceutical Ingredients Market in Saudi Arabia 2020–2026 ($ billion)
Exhibit 88 Active Pharmaceutical Ingredients Market in South Africa 2020–2026 ($ billion)
Exhibit 89 Active Pharmaceutical Ingredients Market in UAE 2020–2026 ($ billion)
LIST OF TABLES
Table 1 Key Caveats
Table 2 Currency Conversion 2013?2020
Table 3 Global Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 4 Global Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 5 Global Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 6 Global Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 7 Global Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 8 Global Pharmaceutical Ingredients Market by Region 2020–2026 ($ billion)
Table 9 Global Oncology APIs Market by Geography 2020–2026 ($ billion)
Table 10 Global Diabetes APIs Market by Geography 2020–2026 ($ billion)
Table 11 Global Cardiovascular APIs Market by Geography 2020–2026 ($ billion)
Table 12 Global Respiratory Diseases APIs Market by Geography 2020–2026 ($ billion)
Table 13 Global Pain Management APIs Market by Geography 2020–2026 ($ billion)
Table 14 Global Anti-infective APIs Market by Geography 2020–2026 ($ billion)
Table 15 Global Central Nervous System APIs Market by Geography 2020–2026 ($ billion)
Table 16 Global Small Molecule APIs Market by Geography 2020–2026 ($ billion)
Table 17 Global Large Molecule APIs Market by Geography 2020–2026 ($ billion)
Table 18 Global Captive Manufacturing APIs Market by Geography 2020–2026 ($ billion)
Table 19 Global Merchant Manufacturing APIs Market by Geography 2020–2026 ($ billion)
Table 20 Global Over-the-counter APIs Market by Geography 2020–2026 ($ billion)
Table 21 Global Prescription Drug APIs Market by Geography 2020–2026 ($ billion)
Table 22 Global Synthetic APIs Market by Geography 2020–2026 ($ billion)
Table 23 Global Biotech APIs Market by Geography 2020–2026 ($ billion)
Table 24 North America Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 25 North America Active Pharmaceutical Ingredients by Molecule 2020–2026 ($ billion)
Table 26 North America Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 27 North America Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 28 North America Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 29 Europe Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 30 Europe Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 31 Europe Active Pharmaceutical Ingredients Market by Manufacturing 2020–2026 ($ billion)
Table 32 Europe Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 33 Europe Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 34 APAC Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 35 APAC Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 36 APAC Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 37 APAC Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 38 APAC Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 39 Latin America Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 40 Latin America Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 41 Latin America Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 42 Latin America Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 43 Latin America Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 44 MEA Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 45 MEA Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 46 MEA Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 47 MEA Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 48 MEA Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 49 Pfizer Inc.: Major Product Offerings
Table 50 Cipla Inc.: Major Product Offerings
Table 51 Novartis AG: Major Product Offerings
Table 52 Mylan N.V.: Major Product Offerings
Table 53 Sun Pharmaceutical Industries Ltd.: Major Product Offerings
Table 54 Global Oncology Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 55 Global Oncology Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 56 Global Cardiovascular Disease Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 57 Global Cardiovascular Disease Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 58 Global Anti-infectives Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 59 Global Anti-infectives Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 60 Global CNS Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 61 Global CNS Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 62 Global Pain Management Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 63 Global Pain Management Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 64 Global Diabetes Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 65 Global Diabetes Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 66 Global Respiratory Disease Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 67 Global Respiratory Disease Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 68 Global Small Molecule Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 69 Global Small Molecule Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 70 Global Large Molecule Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 71 Global Large Molecule Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 72 Global Synthetic Active Pharmaceutical Ingredients Market by Geography 2020?2026 ($ billion)
Table 73 Global Synthetic Active Pharmaceutical Ingredients Market by Geography 2020?2026 (% share)
Table 74 Global Biotech Active Pharmaceutical Ingredients Market by Geography 2020?2026 ($ billion)
Table 75 Global Biotech Active Pharmaceutical Ingredients Market by Geography 2020?2026 (% share)
Table 76 Global Captive Manufacturing Active Pharmaceutical Ingredients Market by Geography 2020?2026 ($ billion)
Table 77 Global Captive Manufacturing Active Pharmaceutical Ingredients Market by Geography 2020?2026 (% share)
Table 78 Global Merchant Manufacturing Active Pharmaceutical Ingredients Market by Geography 2020?2026 ($ billion)
Table 79 Global Merchant Manufacturing Active Pharmaceutical Ingredients Market by Geography 2020?2026 (% share)
Table 80 Global OTC Drug Active Pharmaceutical Ingredients Market by Geography 2020?2026 ($ billion)
Table 81 Global OTC Drug Active Pharmaceutical Ingredients Market by Geography 2020?2026 (% share)
Table 82 Global Prescription Drugs Active Pharmaceutical Ingredients Market by Geography 2020?2026 ($ billion)
Table 83 Global Prescription Drugs Active Pharmaceutical Ingredients Market by Geography 2020?2026 (% share)
Table 84 North America Active Pharmaceutical Ingredients Market by Application 2020?2026 ($ billion)
Table 85 North America Active Pharmaceutical Ingredients Market by Application 2020?2026 (% share)
Table 86 North America Active Pharmaceutical Ingredients Market by Molecule 2020?2026 ($ billion)
Table 87 North America Active Pharmaceutical Ingredients Market by Molecule 2020?2026 (% share)
Table 88 North America Active Pharmaceutical Ingredients Market by Manufacturing 2020?2026 ($ billion)
Table 89 North America Active Pharmaceutical Ingredients Market by Manufacturing 2020?2026 (% share)
Table 90 North America Active Pharmaceutical Ingredients Market by Synthesis 2020?2026 ($ billion)
Table 91 North America Active Pharmaceutical Ingredients Market by Synthesis 2020?2026 (% share)
Table 92 North America Active Pharmaceutical Ingredients Market by Drugs 2020?2026 ($ billion)
Table 93 North America Active Pharmaceutical Ingredients Market by Drugs 2020?2026 (% share)
Table 94 Europe Active Pharmaceutical Ingredients Market by Application 2020?2026 ($ billion)
Table 95 Europe Active Pharmaceutical Ingredients Market by Application 2020?2026 (% share)
Table 96 Europe Active Pharmaceutical Ingredients Market by Molecule 2020?2026 ($ billion)
Table 97 Europe Active Pharmaceutical Ingredients Market by Molecule 2020?2026 (% share)
Table 98 Europe Active Pharmaceutical Ingredients Market by Manufacturing 2020?2026 ($ billion)
Table 99 Europe Active Pharmaceutical Ingredients Market by Manufacturing 2020?2026 (% share)
Table 100 Europe Active Pharmaceutical Ingredients Market by Synthesis 2020?2026 ($ billion)
Table 101 Europe Active Pharmaceutical Ingredients Market by Synthesis 2020?2026 (% share)
Table 102 Europe Active Pharmaceutical Ingredients Market by Drugs 2020?2026 ($ billion)
Table 103 Europe Active Pharmaceutical Ingredients by Drugs 2020?2026 (% share)
Table 104 APAC Active Pharmaceutical Ingredients Market by Application 2020?2026 ($ billion)
Table 105 APAC Active Pharmaceutical Ingredients Market by Application 2020?2026 (% share)
Table 106 APAC Active Pharmaceutical Ingredients Market by Molecule 2020?2026 ($ billion)
Table 107 APAC Active Pharmaceutical Ingredients Market by Molecule 2020?2026 (% share)
Table 108 APAC Active Pharmaceutical Ingredients Market by Manufacturers 2020?2026 ($ billion)
Table 109 APAC Active Pharmaceutical Ingredients Market by Manufacturers 2020?2026 (% share)
Table 110 APAC Active Pharmaceutical Ingredients Market by Synthesis 2020?2026 ($ billion)
Table 111 APAC Active Pharmaceutical Ingredients Market by Synthesis 2020?2026 (% share)
Table 112 APAC Active Pharmaceutical Ingredients Market by Drugs 2020?2026 ($ billion)
Table 113 APAC Active Pharmaceutical Ingredients Market by Drugs 2020?2026 (% share)
Table 114 Latin America Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 115 Latin America Active Pharmaceutical Ingredients Market by Application 2020–2026 (% share)
Table 116 Latin America Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 117 Latin America Active Pharmaceutical Ingredients Market by Molecule 2020–2026 (% share)
Table 118 Latin America Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 119 Latin America Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 (% share)
Table 120 Latin America Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 121 Latin America Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 (% share)
Table 122 Latin America Active Pharmaceutical Ingredients Market by Drugs 2020?2026 ($ billion)
Table 123 Latin America Active Pharmaceutical Ingredients Market by Drugs 2020–2026 (% share)
Table 124 MEA Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 125 MEA Active Pharmaceutical Ingredients Market by Application 2020–2026 (% share)
Table 126 MEA Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 127 MEA Active Pharmaceutical Ingredients Market by Molecule 2020–2026 (% share)
Table 128 MEA Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 129 MEA Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 (% share)
Table 130 MEA Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 131 MEA Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 (% share)
Table 132 MEA Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 133 MEA Active Pharmaceutical Ingredients Market by Drugs 2020–2026 (% share)
Table 1 Key Caveats
Table 2 Currency Conversion 2013?2020
Table 3 Global Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 4 Global Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 5 Global Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 6 Global Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 7 Global Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 8 Global Pharmaceutical Ingredients Market by Region 2020–2026 ($ billion)
Table 9 Global Oncology APIs Market by Geography 2020–2026 ($ billion)
Table 10 Global Diabetes APIs Market by Geography 2020–2026 ($ billion)
Table 11 Global Cardiovascular APIs Market by Geography 2020–2026 ($ billion)
Table 12 Global Respiratory Diseases APIs Market by Geography 2020–2026 ($ billion)
Table 13 Global Pain Management APIs Market by Geography 2020–2026 ($ billion)
Table 14 Global Anti-infective APIs Market by Geography 2020–2026 ($ billion)
Table 15 Global Central Nervous System APIs Market by Geography 2020–2026 ($ billion)
Table 16 Global Small Molecule APIs Market by Geography 2020–2026 ($ billion)
Table 17 Global Large Molecule APIs Market by Geography 2020–2026 ($ billion)
Table 18 Global Captive Manufacturing APIs Market by Geography 2020–2026 ($ billion)
Table 19 Global Merchant Manufacturing APIs Market by Geography 2020–2026 ($ billion)
Table 20 Global Over-the-counter APIs Market by Geography 2020–2026 ($ billion)
Table 21 Global Prescription Drug APIs Market by Geography 2020–2026 ($ billion)
Table 22 Global Synthetic APIs Market by Geography 2020–2026 ($ billion)
Table 23 Global Biotech APIs Market by Geography 2020–2026 ($ billion)
Table 24 North America Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 25 North America Active Pharmaceutical Ingredients by Molecule 2020–2026 ($ billion)
Table 26 North America Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 27 North America Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 28 North America Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 29 Europe Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 30 Europe Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 31 Europe Active Pharmaceutical Ingredients Market by Manufacturing 2020–2026 ($ billion)
Table 32 Europe Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 33 Europe Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 34 APAC Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 35 APAC Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 36 APAC Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 37 APAC Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 38 APAC Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 39 Latin America Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 40 Latin America Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 41 Latin America Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 42 Latin America Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 43 Latin America Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 44 MEA Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 45 MEA Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 46 MEA Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 47 MEA Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 48 MEA Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 49 Pfizer Inc.: Major Product Offerings
Table 50 Cipla Inc.: Major Product Offerings
Table 51 Novartis AG: Major Product Offerings
Table 52 Mylan N.V.: Major Product Offerings
Table 53 Sun Pharmaceutical Industries Ltd.: Major Product Offerings
Table 54 Global Oncology Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 55 Global Oncology Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 56 Global Cardiovascular Disease Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 57 Global Cardiovascular Disease Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 58 Global Anti-infectives Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 59 Global Anti-infectives Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 60 Global CNS Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 61 Global CNS Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 62 Global Pain Management Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 63 Global Pain Management Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 64 Global Diabetes Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 65 Global Diabetes Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 66 Global Respiratory Disease Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 67 Global Respiratory Disease Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 68 Global Small Molecule Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 69 Global Small Molecule Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 70 Global Large Molecule Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 71 Global Large Molecule Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 72 Global Synthetic Active Pharmaceutical Ingredients Market by Geography 2020?2026 ($ billion)
Table 73 Global Synthetic Active Pharmaceutical Ingredients Market by Geography 2020?2026 (% share)
Table 74 Global Biotech Active Pharmaceutical Ingredients Market by Geography 2020?2026 ($ billion)
Table 75 Global Biotech Active Pharmaceutical Ingredients Market by Geography 2020?2026 (% share)
Table 76 Global Captive Manufacturing Active Pharmaceutical Ingredients Market by Geography 2020?2026 ($ billion)
Table 77 Global Captive Manufacturing Active Pharmaceutical Ingredients Market by Geography 2020?2026 (% share)
Table 78 Global Merchant Manufacturing Active Pharmaceutical Ingredients Market by Geography 2020?2026 ($ billion)
Table 79 Global Merchant Manufacturing Active Pharmaceutical Ingredients Market by Geography 2020?2026 (% share)
Table 80 Global OTC Drug Active Pharmaceutical Ingredients Market by Geography 2020?2026 ($ billion)
Table 81 Global OTC Drug Active Pharmaceutical Ingredients Market by Geography 2020?2026 (% share)
Table 82 Global Prescription Drugs Active Pharmaceutical Ingredients Market by Geography 2020?2026 ($ billion)
Table 83 Global Prescription Drugs Active Pharmaceutical Ingredients Market by Geography 2020?2026 (% share)
Table 84 North America Active Pharmaceutical Ingredients Market by Application 2020?2026 ($ billion)
Table 85 North America Active Pharmaceutical Ingredients Market by Application 2020?2026 (% share)
Table 86 North America Active Pharmaceutical Ingredients Market by Molecule 2020?2026 ($ billion)
Table 87 North America Active Pharmaceutical Ingredients Market by Molecule 2020?2026 (% share)
Table 88 North America Active Pharmaceutical Ingredients Market by Manufacturing 2020?2026 ($ billion)
Table 89 North America Active Pharmaceutical Ingredients Market by Manufacturing 2020?2026 (% share)
Table 90 North America Active Pharmaceutical Ingredients Market by Synthesis 2020?2026 ($ billion)
Table 91 North America Active Pharmaceutical Ingredients Market by Synthesis 2020?2026 (% share)
Table 92 North America Active Pharmaceutical Ingredients Market by Drugs 2020?2026 ($ billion)
Table 93 North America Active Pharmaceutical Ingredients Market by Drugs 2020?2026 (% share)
Table 94 Europe Active Pharmaceutical Ingredients Market by Application 2020?2026 ($ billion)
Table 95 Europe Active Pharmaceutical Ingredients Market by Application 2020?2026 (% share)
Table 96 Europe Active Pharmaceutical Ingredients Market by Molecule 2020?2026 ($ billion)
Table 97 Europe Active Pharmaceutical Ingredients Market by Molecule 2020?2026 (% share)
Table 98 Europe Active Pharmaceutical Ingredients Market by Manufacturing 2020?2026 ($ billion)
Table 99 Europe Active Pharmaceutical Ingredients Market by Manufacturing 2020?2026 (% share)
Table 100 Europe Active Pharmaceutical Ingredients Market by Synthesis 2020?2026 ($ billion)
Table 101 Europe Active Pharmaceutical Ingredients Market by Synthesis 2020?2026 (% share)
Table 102 Europe Active Pharmaceutical Ingredients Market by Drugs 2020?2026 ($ billion)
Table 103 Europe Active Pharmaceutical Ingredients by Drugs 2020?2026 (% share)
Table 104 APAC Active Pharmaceutical Ingredients Market by Application 2020?2026 ($ billion)
Table 105 APAC Active Pharmaceutical Ingredients Market by Application 2020?2026 (% share)
Table 106 APAC Active Pharmaceutical Ingredients Market by Molecule 2020?2026 ($ billion)
Table 107 APAC Active Pharmaceutical Ingredients Market by Molecule 2020?2026 (% share)
Table 108 APAC Active Pharmaceutical Ingredients Market by Manufacturers 2020?2026 ($ billion)
Table 109 APAC Active Pharmaceutical Ingredients Market by Manufacturers 2020?2026 (% share)
Table 110 APAC Active Pharmaceutical Ingredients Market by Synthesis 2020?2026 ($ billion)
Table 111 APAC Active Pharmaceutical Ingredients Market by Synthesis 2020?2026 (% share)
Table 112 APAC Active Pharmaceutical Ingredients Market by Drugs 2020?2026 ($ billion)
Table 113 APAC Active Pharmaceutical Ingredients Market by Drugs 2020?2026 (% share)
Table 114 Latin America Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 115 Latin America Active Pharmaceutical Ingredients Market by Application 2020–2026 (% share)
Table 116 Latin America Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 117 Latin America Active Pharmaceutical Ingredients Market by Molecule 2020–2026 (% share)
Table 118 Latin America Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 119 Latin America Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 (% share)
Table 120 Latin America Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 121 Latin America Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 (% share)
Table 122 Latin America Active Pharmaceutical Ingredients Market by Drugs 2020?2026 ($ billion)
Table 123 Latin America Active Pharmaceutical Ingredients Market by Drugs 2020–2026 (% share)
Table 124 MEA Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 125 MEA Active Pharmaceutical Ingredients Market by Application 2020–2026 (% share)
Table 126 MEA Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 127 MEA Active Pharmaceutical Ingredients Market by Molecule 2020–2026 (% share)
Table 128 MEA Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 129 MEA Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 (% share)
Table 130 MEA Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 131 MEA Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 (% share)
Table 132 MEA Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 133 MEA Active Pharmaceutical Ingredients Market by Drugs 2020–2026 (% share)
